John V Forrester Selected Research

Posterior Uveitis

07/2007	Interferon-alpha as an effective treatment for noninfectious posterior uveitis and panuveitis.
06/2004	Neutralizing tumor necrosis factor activity leads to remission in patients with refractory noninfectious posterior uveitis.

4	Inflammation 10/2008 - 08/2003
2	Posterior Uveitis 07/2007 - 06/2004
1	Vasculitis (Vasculitides) 04/2008
1	Leukostasis 11/2007
1	Diabetic Retinopathy (Retinopathy, Diabetic) 11/2007
1	Uveitis 09/2007
1	Panuveitis 07/2007
1	Vitiligo 09/2006
1	Autoimmune Diseases (Autoimmune Disease) 09/2006
1	Intermediate Uveitis (Chronic Cyclitis) 05/2005
1	Necrosis 11/2004
1	Wounds and Injuries (Trauma) 04/2004

3	Retinaldehyde (Retinal)IBA 10/2008 - 08/2003
2	Interferon-alpha (Interferon Alfa)FDA Link 07/2007 - 09/2006
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2004 - 06/2004
1	mycophenolate mofetil (Cellcept)FDA LinkGeneric 04/2008
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 04/2008
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 11/2007
1	Immunoglobulin E (IgE)IBA 09/2007
1	Fas Ligand Protein (Fas Ligand)IBA 09/2006
1	Tacrolimus (Prograf)FDA Link 05/2005
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 05/2005
1	LeptinIBA 04/2004
1	Insulin (Novolin)FDA Link 04/2004